Site Search

LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of chronic limb-threatening ischemia (CLTI), a severe form of peripheral artery disease (PAD), announced today that the first patient has been treated in its…

Vascular Disease Management talks with IMPERIAL trial co-principal investigator William A. Gray, MD, FACC, FSCAI, System Chief, Division of Cardiovascular Disease; President, Lankenau Heart Institute, Main Line Health, Wynnewood, Pennsylvania.

Craig Walker, MD, comments on the results of a pilot study by Nugroho and colleagues in which young patients with mild PAD showed a significant increase in serum VEGF after only 8 weeks of exercise therapy.

Alexandrescu and colleagues review the main anatomical features describing infra-popliteal arterial vasculature with, and without, ischemic impairment, in accordance with practical clinical issues encountered in daily practice.

Vascular Disease Management talks with Ravish Sachar, MD, FACC, University of North Carolina - Rex Hospital Physician-in-Chief for Heart and Vascular Services, and Principal Investigator of the RANGER II SFA trial.

Nagel and Adams describe a case that utilizes a personalized approach for access, crossing, and treatment in order to achieve the best outcomes for the patient.

Parikh and colleagues discuss the recently released Global Vascular Guidelines and important new concepts emanating from these guidelines.

Nurgroho and colleagues describe how home-based exercise training improved VEGF level and ABI in patients with PAD.

Dr. Walker comments on a pilot study by Nugroho and colleagues, and how home-based exercise training may increase levels of VEGF in patients with mild PAD.

erit Medical Systems, Inc.,  a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced…